- Q1. What is the business of Cotec Healthcare Limited?
It is an Indian pharmaceutical CDMO offering formulation development & commercial manufacturin alongwith dosage forms including injectables, tablets, capsules, syrups, eye/ear drops and more. - Q2. Why is the company raising funds via IPO?
Cotec Healthcare is raising funds via IPO to expand its manufacturing capacity with new facilities for high-growth products to support future growth. - Q4. What are the risks to an investor?
Risks points for this IPO include industry regulation, customer concentration risk, input cost volatility and competitive pressures in the pharma CDMO segment. - Q5. What are the potential upsides?
Potential upsides to invest in the IPO are growing outsourcing in pharma manufacturing, capacity expansion, strong financial growth and broad formulation capabilities. - Q6. How to apply for the IPO?
You can apply for the IPO via ASBA through your bank’s netbanking or UPI with your Demat account when the IPO window opens through your broker or bank. - Q 7. When is the tentative listing date?
Expected listing date is yet to be announced.
Upcoming
Cotec Healthcare :New IPO,Price, Profit
0
IPO Score
0
*Score varies on actual price
Cotec Healthcare Limited is a pharmaceutical Contract Development and Manufacturing Organisation (CDMO) that develops and manufactures a wide range of formulations including injectables, tablets, capsules, ointments, syrups, eye/ear drops and other dosage forms for institutional and private clients. The company is reported to be one of India’s largest CDMO players with capabilities across multiple formulation types. The company has filed its DRHP with SEBI for an IPO proposed of fresh issue of shares aggregating up to ₹295 crore and OFS of up to 0.60 Cr equity shares by promoters.
Cotec Healthcare Limited was incorporated in the year 1998.Mr. Harsh Tiwari serves as Managing Director and CEO of the company.
It offers contract development and manufacturing services (CDMO) and production of pharmaceutical formulations such as injectables, tablets, capsules, syrups, ointments, eye/ear drops, ampoules, vials, and nutraceuticals for institutional and private clients.It served over 154 customers in FY25 with operations across 24 states/UTs in India and exports to 14 countries, and is recognised as the second-largest CDMO in India by number of dosage forms, reflecting meaningful market presence.
Subscription date to apply for Cotec Healthcare Limited is yet to be announced. Price band for the IPO is yet to be declared.
Revenue, PAT, EBITDA
|
Year
|
2025
|
|---|---|
|
Networth
|
₹ 59 Cr
|
|
Revenue
|
₹ 192.2 Cr
|
|
EBITDA
|
₹ 31.4 Cr
|
|
PAT
|
₹ 20 Cr
|
|
EBITDA Margin
|
~16.36%
|
|
PAT Margin
|
~10.40%
|
|
Face Value
|
Rs.05 per Equity Share
|
IPO Important Dates
|
#
|
Date
|
|---|---|
|
Open Date
|
TBA
|
|
Close Date
|
TBA
|
|
Anchor Investor Bidding
|
TBA
|
|
Allotment Date
|
TBA
|
|
Refunds& Demat Credit
|
TBA
|
|
Tentative Listing Date
|
TBA
|
Use Of Proceeds
|
Purpose
|
Amount
|
|---|---|
|
Setting up new Project to manufacture new product
|
~ ₹ 226.25 Cr
|
|
-
|
-
|
|
-
|
-
|
|
-
|
-
|
|
-
|
-
|
|
-
|
-
|
Financial Data
|
#
|
2023
|
2024
|
2025
|
|---|---|---|---|
|
Revenue (₹ Cr)
|
82.42
|
137.99
|
192.23
|
|
PAT (₹ Cr)
|
5.03
|
10.46
|
20
|
|
Asset (₹ Cr)
|
68.64
|
95.82
|
136.62
|
|
Net Worth (₹ Cr)
|
28.34
|
38.89
|
58.97
|
IPO Grey Market Premium
|
Date
|
IPO Price
|
IPO GMP
|
Profit Per Lot
|
|---|---|---|---|
|
08-Aug
|
₹ –
|
₹ –
|
₹ –
|
|
07-Aug
|
₹ –
|
₹ –
|
₹ –
|
|
06-Aug
|
₹ –
|
₹ –
|
₹ –
|
|
05-Aug
|
₹ –
|
₹ –
|
₹ –
|
|
04-Aug
|
₹ –
|
₹ –
|
₹ –
|
Promoters – Pre offer equity (Approx)
|
Promoters
|
% Shares
|
|---|---|
|
Harsh Tiwari
|
~73.72%
|
|
Vandana Tiwari
|
~24.37%
|
|
-
|
-
|
|
-
|
-
|
|
-
|
-
|
|
-
|
-
|
Lot Size details
|
Application Type
|
Lot Size
|
No. of Lot
|
No. of Shares
|
Investment Amount
|
|---|---|---|---|---|
|
Retail (Min)
|
–
|
1
|
–
|
₹ –
|
|
Retail (Max)
|
–
|
13
|
–
|
₹ -
|
|
HNI (Min)
|
–
|
14
|
–
|
₹ –
|
|
HNI (Max)
|
–
|
66
|
–
|
₹ –
|
|
Big HNI (Min)
|
–
|
67
|
–
|
₹ –
|
Key Performance Index (KPI)
|
ROE
|
00
|
|---|---|
|
ROCE
|
00
|
|
RoNW
|
00
|
JOIN OUR SOCIAL-MEDIA PLATFORMS TO STAY UPDATED
